Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease.

Jones, Richard J; Seaman, William T; Feng, Wen-Hei; Barlow, Elizabeth; Dickerson, Sarah; Delecluse, Henri-Jacque; Kenney, Shannon C

Jones, Richard J; Seaman, William T; Feng, Wen-Hei; Barlow, Elizabeth; Dickerson, Sarah; Delecluse, Henri-Jacque; Kenney, Shannon C.

Affiliation

Jones RJ; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.

Int J Cancer ; 121(6): 1274-81, 2007 Sep 15.

Article in En | MEDLINE | ID: mdl-17520680

Subject(s)

Epstein-Barr Virus Infections/metabolism; Interleukin-6/metabolism; Lymphoproliferative Disorders/virology; Tumor Virus Infections/virology; Animals; Cell Line, Tumor; DNA-Binding Proteins/metabolism; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Immediate-Early Proteins/metabolism; Immunoblotting; Interleukin-10/metabolism; Lymphoproliferative Disorders/metabolism; Mice; Mice, SCID; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Trans-Activators/metabolism; Tumor Virus Infections/metabolism; Viral Matrix Proteins/metabolism; Viral Proteins/metabolism

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tumor Virus Infections / Interleukin-6 / Epstein-Barr Virus Infections / Lymphoproliferative Disorders Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Int J Cancer Year: 2007 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links